Correction to: The direct effect of SARS-CoV-2 virus vaccination on human ovarian granulosa cells explains menstrual irregularities (npj Vaccines, (2024), 9, 1, (117), 10.1038/s41541-024-00911-2)

Hadas Bar-Joseph, Yael Raz, Anat Eldar-Boock, Nadav Michaan, Yoel Angel, Esther Saiag, Luba Nemerovsky, Ido Ben-Ami, Ruth Shalgi, Dan Grisaru*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

Correction to: npj Vaccineshttps://doi.org/10.1038/s41541-024-00911-2, published online 26 June 2024 In the original version of this Article, the vaccine concentrations used in the in vitro experiments were written mistakenly with a 10-fold error. The actual concentration used was 0.5 μg/ml resulting in a 0.5 pg/ml end-organ dose (Discussion). In Methods section Stimulation “of injected dose” was missing after “~0.1%”, and the final concentration of vaccine in blood should have been 0.006 μg/ml. A clarification is added that “This concentration also mimics ~0.8% of the IM injected dose found in the Plasma 1 h post injection.” Throughout the rest of the Methods the stock concentration should have been 500 μg/ml and the injected dose 0.5 μg/ml. The Article has now been corrected with these changes. This correction does not change the scientific conclusions of the article.

Original languageEnglish
Article number172
Journalnpj Vaccines
Volume9
Issue number1
DOIs
StatePublished - Dec 2024

Fingerprint

Dive into the research topics of 'Correction to: The direct effect of SARS-CoV-2 virus vaccination on human ovarian granulosa cells explains menstrual irregularities (npj Vaccines, (2024), 9, 1, (117), 10.1038/s41541-024-00911-2)'. Together they form a unique fingerprint.

Cite this